Pharvaris
Eivind has a strong background in clinical research and pharmaceutical operations, with experience at top companies such as Pharvaris, Syneos Health, Sanofi, and ICON plc. With a Master's Degree in Biomedical Sciences Management from Leiden University and a Bachelor's Degree in Biological Sciences from The University of Edinburgh, Eivind has developed a comprehensive skill set in research and project management. Additionally, Eivind has demonstrated a proficiency in developing and implementing performance tracking systems, conducting validation studies, and working with various laboratory techniques in different internships throughout their academic and professional career.
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.